Your session is about to expire
← Back to Search
Dietary Supplement
Fiber Inulin for Chronic Obstructive Pulmonary Disease
N/A
Waitlist Available
Led By Marielle Engelen
Research Sponsored by Texas A&M University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 1, 2, 4, and 5
Summary
This trial is testing inulin, a type of dietary fiber, in patients with COPD. The goal is to see if fiber can help improve their condition by being broken down into substances that reduce inflammation and support the immune system. Inulin has been studied for its potential benefits in managing type 2 diabetes mellitus, including improving glycemic control and antioxidant status.
Eligible Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Aging
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ screening visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~screening visit
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Intestinal microbiota composition by stool sample collection using Shallow Shotgun Sequencing
Whole body short-chain fatty acid production rates by plasma samples
Secondary study objectives
3-day diet diary
6 minute walk test distance
Attention and executive functions measured by Stroop Color-Word Test (SCWT)
+19 moreTrial Design
3Treatment groups
Experimental Treatment
Group I: Healthy Young ParticipantsExperimental Treatment2 Interventions
healthy young subjects with age 18-30 years old
Group II: Healthy ParticipantsExperimental Treatment2 Interventions
healthy control subjects
Group III: Chronic Obstructive Pulmonary Disease patientsExperimental Treatment2 Interventions
Established diagnosis of Chronic Obstructive Pulmonary Disease
Find a Location
Who is running the clinical trial?
Texas A&M UniversityLead Sponsor
148 Previous Clinical Trials
23,317 Total Patients Enrolled
Marielle EngelenPrincipal InvestigatorTexas A&M University - CTRAL
4 Previous Clinical Trials
234 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You had a fever in the past three days.You have taken oral corticosteroids for a short period of time within the past 4 weeks before the study.You have been taking fiber supplements every day for a week before the first test day.You are allergic to inulin, maltodextrin, or any of the ingredients in the study.You have diabetes that requires insulin for treatment.If the doctor or nurse finds any other health condition during the screening visit that could affect your safety or the study, you may not be able to participate.You do not have a diagnosis of COPD (chronic obstructive pulmonary disease).You can comfortably lie down flat or with your upper body elevated for 1.5 hours.You have a history of untreated liver or kidney problems.You have a serious illness that is not stable or well-controlled.You have been taking protein supplements every day for the 5 days leading up to the test.You are allergic to inulin or products containing inulin.You have difficulty breathing when you do physical activities.You have been feeling well and haven't had a respiratory infection or worsening of your condition for at least 4 weeks before the first test day.
Research Study Groups:
This trial has the following groups:- Group 1: Chronic Obstructive Pulmonary Disease patients
- Group 2: Healthy Participants
- Group 3: Healthy Young Participants
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger